Biography
Peter P. Sordillo, M.D., PhD, M.S. is a physician and cancer researcher and physics researcher whose specialty is the treatment of extremely rare cancers. In addition to his M.D., he holds three graduate degrees in philosophy (causality) (Columbia University), and a graduate degree in physics (NYU). He is Vice-President and Chief Scientific and Medical Officer at SignPath Pharma Inc., a biotechnology firm studying new treatments for cardiac diseases and for cancer. Dr. Sordillo was, for many years, an attending oncologist and cancer researcher at Memorial Sloan-Kettering Cancer Center and The Sloan-Kettering Institute, where he did important research on the treatment of soft-tissue sarcomas and other cancers, and he directed numerous clinical trials of experimental cancer medications. He is now Attending Physician in Oncology, Hematology and Internal Medicine at Lenox Hill Hospital in Manhattan. He is author of 180 journal articles, book chapters and conference proceedings, and is co-editor of two books on applications of new techniques in physics, including the recently published "Biophotonics, Tryptophan and Disease," from Elsevier/Academic Press and "Short-Wavelength Infrared Windows for Biomedical Applications" from SPIE Press.
Contact Form
Degrees
|
New York University, New York, NY M.S. (Physics), 2001 (Quantum information theory and quantum computing)
Columbia University, New York, NY Ph.D. in Philosophy, 1990 (Quantum physics and causality) Columbia University, New York, NY M.Phil. in Philosophy, 1982 (Qualifications in epistemology, logic, metaphysics, German) Columbia University, New York, NY M.A. in Philosophy, 1980 (Qualifications in ethics, philosophy of science, political philosophy, French) New York Medical College, New York, NY M.D., 1977 Columbia College, New York, NY A.B., 1970 |
|
Honors and Awards
Fellow – American College of Physicians 1984 - 2010
American Cancer Society, Junior Faculty Clinical Award
1st year award 1982 - 1983
2nd year award 1983 - 1984
3rd year award 1984 - 1985
Memorial Sloan-Kettering Cancer Center Basic Science Research Award "The Effects of Chemotherapy on Tumor Cell Growth in the Nude Mouse" 1979
National Research Service Award National Cancer Institute 1978 – 1979
Fellow American Cancer Society, 1977 - 1978
American Cancer Society, Junior Faculty Clinical Award
1st year award 1982 - 1983
2nd year award 1983 - 1984
3rd year award 1984 - 1985
Memorial Sloan-Kettering Cancer Center Basic Science Research Award "The Effects of Chemotherapy on Tumor Cell Growth in the Nude Mouse" 1979
National Research Service Award National Cancer Institute 1978 – 1979
Fellow American Cancer Society, 1977 - 1978
Patents
Sordillo, P.P.: Dosing Regimens for Treatment of Proliferative Disorders. US Patent Application 17/045,431 (June 3rd, 2021).
Hocking, A., Sordillo, P.P., Farrall, A.L.: Treatment for Malignant Pleural Effusion in Humans. US Patent, Serial No. 63/156,090 (March 3rd, 2021).
Sordillo, P.P., Allaire, A., Bouchard, A., Salvail, D., Labbel, S.M.: Lipids that Reduce Lung Damage, Improve Pulmonary Function and Decrease Pro-Inflammatory Cytokines. US Patent, Serial No. 63/143,511 (January 29th, 2021).
Sordillo, P.P., Helson L., Burgess, S.W., Shaw, W.A.: Suppression of cytokine release and cytokine storm. US Patent, Serial No. 10,739,353 (August 11th, 2020).
Sordillo, L.A., Sordillo, P.P., Helson, L.: Treatment for Glioblastoma. EP Patent No. EP3144006B1 (June 17th, 2020).
Sordillo, L.A., Sordillo, P.P., Helson, L.: Treatment for Glioblastoma. US Patent No. US20170079934A1 (November 26th, 2019).
Sordillo, L.A., Sordillo, P.P., Helson, L.: Treatment for Glioblastoma. CA Patent No. CA2940470A (August 20th, 2019).
Sordillo, P.P.: Dosing regimens for treatment of proliferative disorders. US Patent, Serial No. 62/655,095, 2018.
Helson, L., Sordillo, L.A., Sordillo, P.P.: Sphingosine kinase inhibitors and ceramide for maintenance therapy of glioblastoma. TW Patent No. TW201740927A (December 1st, 2017).
Helson, L., Sordillo, L.A., Sordillo, P.P.: Sphingosine kinase inhibitors and ceramide for maintenance therapy of glioblastoma. WO Patent No. WO2017151360A1 (September 8th, 2017).
Helson, L., Sordillo, L.A., Sordillo, P.P.: Sphingosine kinase inhibitors and ceramide for maintenance therapy of glioblastoma. US Patent, Serial No. 15/439,405 (February 22nd, 2017).
Alfano, R.R., Sordillo, L.A., Sordillo, P.P.: Optical histology: double ratio methods for the rapid, label-free, non-invasive assessment of diseases. US Patent, Serial No. 62/230,063 (May 27th, 2015).
Sordillo, P.P., Helson, L, Burgess S.W and Shaw W.A.: Suppression of Cytokine Release and Cytokine Storm. #20, 160, 184, 330.
Sordillo, D.C., Sordillo, P.P. and Helson, L.: Curcumin for Treating Intervertebral Disc Disease.
Hocking, A., Sordillo, P.P., Farrall, A.L.: Treatment for Malignant Pleural Effusion in Humans. US Patent, Serial No. 63/156,090 (March 3rd, 2021).
Sordillo, P.P., Allaire, A., Bouchard, A., Salvail, D., Labbel, S.M.: Lipids that Reduce Lung Damage, Improve Pulmonary Function and Decrease Pro-Inflammatory Cytokines. US Patent, Serial No. 63/143,511 (January 29th, 2021).
Sordillo, P.P., Helson L., Burgess, S.W., Shaw, W.A.: Suppression of cytokine release and cytokine storm. US Patent, Serial No. 10,739,353 (August 11th, 2020).
Sordillo, L.A., Sordillo, P.P., Helson, L.: Treatment for Glioblastoma. EP Patent No. EP3144006B1 (June 17th, 2020).
Sordillo, L.A., Sordillo, P.P., Helson, L.: Treatment for Glioblastoma. US Patent No. US20170079934A1 (November 26th, 2019).
Sordillo, L.A., Sordillo, P.P., Helson, L.: Treatment for Glioblastoma. CA Patent No. CA2940470A (August 20th, 2019).
Sordillo, P.P.: Dosing regimens for treatment of proliferative disorders. US Patent, Serial No. 62/655,095, 2018.
Helson, L., Sordillo, L.A., Sordillo, P.P.: Sphingosine kinase inhibitors and ceramide for maintenance therapy of glioblastoma. TW Patent No. TW201740927A (December 1st, 2017).
Helson, L., Sordillo, L.A., Sordillo, P.P.: Sphingosine kinase inhibitors and ceramide for maintenance therapy of glioblastoma. WO Patent No. WO2017151360A1 (September 8th, 2017).
Helson, L., Sordillo, L.A., Sordillo, P.P.: Sphingosine kinase inhibitors and ceramide for maintenance therapy of glioblastoma. US Patent, Serial No. 15/439,405 (February 22nd, 2017).
Alfano, R.R., Sordillo, L.A., Sordillo, P.P.: Optical histology: double ratio methods for the rapid, label-free, non-invasive assessment of diseases. US Patent, Serial No. 62/230,063 (May 27th, 2015).
Sordillo, P.P., Helson, L, Burgess S.W and Shaw W.A.: Suppression of Cytokine Release and Cytokine Storm. #20, 160, 184, 330.
Sordillo, D.C., Sordillo, P.P. and Helson, L.: Curcumin for Treating Intervertebral Disc Disease.
Board Certifications
Diplomate of American Board of Medical Oncology, 1981
Diplomate of American Board of Internal Medicine, 1977
Diplomate of American Board of Internal Medicine, 1977